Table 2 Clinical characteristics of the participants
Variables | CCTH n = 217 (55.1%) | CCMH n = 28 (7.1%) | SMH n = 149 (37.8%) | Total N (%) |
|---|---|---|---|---|
HIV patients | ||||
Newly confirmed cases | 29 (13.4) | 7 (25.0) | 11 (7.4) | 47 (11.9) |
Old cases | 188 (86.6) | 21 (75.0) | 138 (92.6) | 347 (88.1) |
WHO clinical stage | ||||
Stage 1 | 137 (63.1) | 20((71.4) | 114 (76.5) | 271 (68.8) |
Stage 2 | 52 (24.0) | 4 (14.3) | 22 (14.8) | 78 (19.8) |
Stage 3 | 21 (9.7) | 1 (3.6) | 7 (4.7) | 29 (7.4) |
Stage 4 | 7 (3.2) | 3 (10.7) | 6 (4.0) | 16 (4.1) |
HBV/HCV status before testing | ||||
HBV known | 19 [4*] (21.1) | 0 (0) | 12(P = 1; 8.3) | 31 (7.9) |
HBV unknown | 198 (91.2) | 28 (100) | 137 (91.9) | 363 (92.1) |
HCV unknown | 217 (100) | 28 (100) | 149 (100) | 394 (100) |